Table 1 Baseline characteristics of the study population according to the type of glomerular disease

Age (years)

42.38 ± 15.97^de

39.16 ± 14.42 ^d

42.68 ± 22.16 ^d

66.59 ± 8.74 ^abc

58.78 ± 10.92^a

39.43 ± 15.21

Male (n, %)

99 (49.5%)

0 (0.0%)

9 (56.3%)

6 (35.3%)

5 (55.6%)

18 (23.7%)

BMI (kg/m²)

23.89 ± 3.43

22.4 ± 2.76

25.25 ± 3.77

23.52 ± 3.61

24.03 ± 1.63

-

HTN (n, %)

73 (36.5%)

2 (33.3%)

5 (31.3%)

6 (35.2%)

3 (33.3%)

-

DM (n, %)

12 (6.0%)

0 (0.0%)

1 (6.2%)

2 (11.8%)

1 (11.1%)

-

Albumin (g/dL)

3.90 ± 0.53^bcde

2.87 ± 0.72^a

2.51 ± 0.9^ade

3.19 ± 0.48^ac

3.20 ± 0.77^ac

-

IgA (mg/dL)

305.11 ± 94.99

265.67 ± 117.46

273.06 ± 85.03

290.35 ± 101.09

210.33 ± 66.59

-

Creatinine (mg/dL)

1.32 ± 1.24 ^d

0.94 ± 0.64 ^d

1.20 ± 0.90 ^d

4.18 ± 2.67 ^abce

0.69 ± 0.21 ^d

-

eGFR (ml/min/1.73 m2)

80.48 ± 37.23^d

95.20 ± 49.81^d

87.06 ± 43.45^d

24.07 ± 31.38^abce

99.24 ± 23.28 ^d

-

Urine PCR (g/gCr)

1.64 ± 2.04 ^cef

2.54 ± 2.26^cef

9.84 ± 6.79 ^abdf

2.26 ± 1.13^cef

6.89 ± 4.71^abdf

0.09 ± 0.06

Urine RBC grade

 < 5/HPF

45 (22.5%)

1 (16.7%)

10 (62.5%)

1 (5.9%)

3 (33.3%)

-

 5–9/HPF

28 (14.0%)

1 (16.7%)

4 (25.0%)

2 (11.8%)

1 (11.1%)

-

 10–29/HPF

47 (23.5%)

2 (33.3%)

1 (6.3%)

4 (23.5%)

2 (22.2%)

-

 ≥ 30/HPF

80 (40.0%)

2 (33.3%)

1 (6.3%)

10 (58.8%)

3 (33.3%)

-